Endothelial progenitor cell dysfunction in cardiovascular diseases: Role of reactive oxygen species and inflammation

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Lin, Chih Pei ^a,b   Lin, Feng Yen ^c   Huang, Po Hsun ^a,b   Chen, Yuh Lien ^d   Chen, Wen Chi ^e,f   Chen, Huey Yi ^e,f   Huang, Yu Chuen ^e,f   Liao, Wen Ling ^e,f   Huang, Huey Chun ^e   Liu, Po Len ^g   Chen, Yung Hsiang ^e,f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CELL FUNCTION; ENDOTHELIAL PROGENITOR CELL; HUMAN; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; REVIEW; ANIMAL; ENDOTHELIUM CELL; METABOLISM; PATHOLOGY; STEM CELL;

ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; STEM CELLS;

EID: 84874602308     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/845037     Document Type: Review

References (119)

1. Liu J. T., Chen Y. L., Chen W. C., Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization. Journal of Biomedicine and Biotechnology 2012 2012 10 871272 10.1155/2012/871272
2. Zaragoza C., Gomez-Guerrero C., Martin-Ventura J. L., Animal models of cardiovascular diseases. Journal of Biomedicine and Biotechnology 2011 2011 13 497841 10.1155/2011/497841
3. Lin C. P., Chen Y. H., Leu H. B., Lin S. J., Chen Y. L., Huang S. L., Chen J. W., Anti-inflammatory strategies for homocysteine-related cardiovascular disease. Frontiers in Bioscience 2009 14 10 3836 3845 2-s2.0-63849097233 10.2735/3492
4. Chen Y. H., Lin S. J., Chen Y. L., Liu P. L., Chen J. W., Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovascular and Hematological Disorders-Drug Targets 2006 6 4 279 304 2-s2.0-33845405725
5. Andreou I., Tousoulis D., Tentolouris C., Antoniades C., Stefanadis C., Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives. Atherosclerosis 2006 189 2 247 254 2-s2.0-33750338182 10.1016/j.atherosclerosis.2006.06.021 (Pubitemid 44634506)
6. Aicher A., Zeiher A. M., Dimmeler S., Mobilizing endothelial progenitor cells. Hypertension 2005 45 3 321 325 2-s2.0-14644442968 10.1161/01.HYP. 0000154789.28695.ea (Pubitemid 40315795)
7. Kirton J. P., Xu Q., Endothelial precursors in vascular repair. Microvascular Research 2010 79 3 193 199 2-s2.0-77952092300 10.1016/j.mvr.2010. 02.009
8. Urbich C., Dimmeler S., Endothelial progenitor cells: characterization and role in vascular biology. Circulation Research 2004 95 4 343 353 2-s2.0-4143052506 10.1161/01.RES.0000137877.89448.78 (Pubitemid 39100452)
9. Reinders M. E. J., Rabelink T. J., Briscoe D. M., Angiogenesis and endothelial cell repair in renal disease and allograft rejection. Journal of the American Society of Nephrology 2006 17 4 932 942 2-s2.0-33645469671 10.1681/ASN.2005121250
10. Cubbon R. M., Kahn M. B., Wheatcroft S. B., Effects of insulin resistance on endothelial progenitor cells and vascular repair. Clinical Science 2009 117 5 173 190 2-s2.0-70349387993 10.1042/CS20080263
11. Simsek S., Van Den Oever I. A. M., Raterman H. G., Nurmohamed M. T., Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators of Inflammation 2010 2010 15 2-s2.0-77954545549 10.1155/2010/792393 792393
12. Du F., Zhou J., Gong R., Endothelial progenitor cells in atherosclerosis. Frontiers in Bioscience 2012 17 2327 2349 10.2741/4055
13. Ribeiro F., Alves A. J., Duarte J. A., Oliveira J., Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation? International Journal of Cardiology 2010 141 3 214 221 2-s2.0-77952880132 10.1016/j.ijcard.2009.09.548
14. Mikirova N. A., Jackson J. A., Hunninghake R., Kenyon J., Chan K. W. H., Swindlehurst C. A., Minev B., Patel A. N., Murphy M. P., Smith L., Alexandrescu D. T., Ichim T. E., Riordan N. H., Circulating endothelial progenitor cells: a new approach to anti-aging medicine? Journal of Translational Medicine 2009 7 106 2-s2.0-74549149967 10.1186/1479-5876-7-106
15. Ungvari Z., Kaley G., De Cabo R., Sonntag W. E., Csiszar A., Mechanisms of vascular aging: new perspectives. Journals of Gerontology A 2010 65 10 1028 1041 2-s2.0-77956938607 10.1093/gerona/glq113
16. Imanishi T., Hano T., Nishio I., Angiotensin II accelarates endothelial progenitor cell senescence through induction of oxidative stress. Journal of Hypertension 2005 23 1 97 104 2-s2.0-12344256734 10.1097/00004872-200501000- 00018 (Pubitemid 40128986)
17. Case J., Ingram D. A., Haneline L. S., Oxidative stress impairs endothelial progenitor cell function. Antioxidants and Redox Signaling 2008 10 11 1895 1907 2-s2.0-51349102077 10.1089/ars.2008.2118
18. Watson T., Goon P. K. Y., Lip G. Y. H., Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. Antioxidants and Redox Signaling 2008 10 6 1079 1088 2-s2.0-41349098142 10.1089/ars.2007.1998 (Pubitemid 351451712)
19. Haubitz M., Woywodt A., Circulating endothelial cells and vasculitis. Internal Medicine 2004 43 8 660 667 2-s2.0-4644265672 10.2169/internalmedicine. 43.660 (Pubitemid 39264163)
20. Stenvinkel P., Pecoits-Filho R., Lindholm B., Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. Journal of the American Society of Nephrology 2003 14 7 1927 1939 2-s2.0-0038544612 10.1097/01.ASN.0000069165.79509.42 (Pubitemid 36750489)
21. Tousoulis D., Andreou I., Antoniades C., Tentolouris C., Stefanadis C., Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. Atherosclerosis 2008 201 2 236 247 2-s2.0-56649095916 10.1016/j. atherosclerosis.2008.05.034
22. Badimon L., Storey R. F., Vilahur G., Update on lipids, inflammation and atherothrombosis. Thrombosis and Haemostasis 2011 105 supplement 1 S34 S42 2-s2.0-79960986843 10.1160/THS10-11-0717
23. Rabelink T. J., De Boer H. C., De Koning E. J. P., Van Zonneveld A. J., Endothelial progenitor cells: more than an inflammatory response? Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 5 834 838 2-s2.0-2442442218 10.1161/01.ATV.0000124891.57581.9f (Pubitemid 38620859)
24. Levenberg S., Engineering blood vessels from stem cells: recent advances and applications. Current Opinion in Biotechnology 2005 16 5 516 523 2-s2.0-25844529379 10.1016/j.copbio.2005.08.007 (Pubitemid 41393831)
25. Abedin M., Tintut Y., Demer L. L., Mesenchymal stem cells and the artery wall. Circulation Research 2004 95 7 671 676 2-s2.0-4944232950 10.1161/01.RES.0000143421.27684.12 (Pubitemid 39331926)
26. Takakura N., Role of hematopoietic lineage cells as accessory components in blood vessel formation. Cancer Science 2006 97 7 568 574 2-s2.0-33745958455 10.1111/j.1349-7006.2006.00223.x (Pubitemid 44056603)
27. Huang H. C., Shi G. Y., Jiang S. J., Shi C. S., Wu C. M., Yang H. Y., Wu H. L., Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain. Journal of Biological Chemistry 2003 278 47 46750 46759 2-s2.0-0344443722 10.1074/jbc.M305216200 (Pubitemid 37452254)
28. Lapidot T., Dar A., Kollet O., How do stem cells find their way home? Blood 2005 106 6 1901 1910 2-s2.0-23244435467 10.1182/blood-2005-04-1417 (Pubitemid 41291700)
29. Isner J. M., Asahara T., Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. Journal of Clinical Investigation 1999 103 9 1231 1236 2-s2.0-0033134604 (Pubitemid 29218292)
30. Goldschmidt-Clermont P. J., Seo D. M., Wang L., Inflammation, stem cells and atherosclerosis genetics. Current Opinion in Molecular Therapeutics 2010 12 6 712 723
31. Patel-Hett S., D'Amore P. A., Signal transduction in vasculogenesis and developmental angiogenesis. International Journal of Developmental Biology 2011 55 4-5 353 369 2-s2.0-79960981005 10.1387/ijdb.103213sp
32. Lu J., Pompili V. J., Das H., Neovascularization and hematopoietic stem cells. Cell Biochemistry and Biophysics. In press
33. Grant M. B., May W. S., Caballero S., Brown G. A. J., Guthrie S. M., Mames R. N., Byrne B. J., Vaught T., Spoerri P. E., Peck A. B., Scott E. W., Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nature Medicine 2002 8 6 607 612 2-s2.0-0036281597 10.1038/nm0602-607 (Pubitemid 34633439)
34. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J. M., Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Research 1999 85 3 221 228 2-s2.0-0033529618 (Pubitemid 29377293)
35. Ii M., Nishimura H., Iwakura A., Wecker A., Eaton E., Asahara T., Losordo D. W., Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via «imported» nitric oxide synthase activity. Circulation 2005 111 9 1114 1120 2-s2.0-14944371450 10.1161/01.CIR.0000157144.24888.7E (Pubitemid 40365471)
36. Bauer S. M., Goldstein L. J., Bauer R. J., Chen H., Putt M., Velazquez O. C., The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. Journal of Vascular Surgery 2006 43 1 134 141 2-s2.0-30544447420 10.1016/j.jvs.2005.08.038 (Pubitemid 43083521)
37. Masuda H., Kalka C., Takahashi T., Yoshida M., Wada M., Kobori M., Itoh R., Iwaguro H., Eguchi M., Iwami Y., Tanaka R., Nakagawa Y., Sugimoto A., Ninomiya S., Hayashi S., Kato S., Asahara T., Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circulation Research 2007 101 6 598 606 2-s2.0-34748813097 10.1161/CIRCRESAHA. 106.144006 (Pubitemid 351325877)
38. Murayama T., Tepper O. M., Silver M., Ma H., Losordo D. W., Isner J. M., Asahara T., Kalka C., Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Experimental Hematology 2002 30 8 967 972 2-s2.0-0036327870 10.1016/S0301-472X(02)00867-6 (Pubitemid 34838899)
39. Moldovan N. I., Asahara T., Role of blood mononuclear cells in recanalization and vascularization of thrombi: past, present, and future. Trends in Cardiovascular Medicine 2003 13 7 265 269 2-s2.0-0141763549 10.1016/S1050-1738(03)00108-7 (Pubitemid 37159390)
40. George A. L., Bangalore-Prakash P., Rajoria S., Suriano R., Shanmugam A., Mittelman A., Tiwari R. K., Endothelial progenitor cell biology in disease and tissue regeneration. Journal of Hematology and Oncology 2011 4 24 2-s2.0-79956285058 10.1186/1756-8722-4-24
41. Folkman J., Shing Y., Angiogenesis. Journal of Biological Chemistry 1992 267 16 10931 10934 2-s2.0-0026639806
42. Jujo K., Ii M., Losordo D. W., Endothelial progenitor cells in neovascularization of infarcted myocardium. Journal of Molecular and Cellular Cardiology 2008 45 4 530 544 2-s2.0-54149095036 10.1016/j.yjmcc.2008.08.003
43. Asahara T., Kawamoto A., Masuda H., Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 2011 29 11 1650 1655 10.1002/stem.745
44. Guzik T. J., Korbut R., Adamek-Guzik T., Nitric oxide and superoxide in inflammation and immune regulation. Journal of Physiology and Pharmacology 2003 54 4 469 487 2-s2.0-0347993913 (Pubitemid 38029745)
45. Hulsmans M., De Keyzer D., Holvoet P., MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. The FASEB Journal 2011 25 8 2515 2527 10.1096/fj.11-181149
46. Schulz E., Gori T., Münzel T., Oxidative stress and endothelial dysfunction in hypertension. Hypertension Research 2011 34 6 665 673 2-s2.0-79958132625 10.1038/hr.2011.39
47. Tousoulis D., Antoniades C., Koumallos N., Stefanadis C., Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine and Growth Factor Reviews 2006 17 4 225 233 2-s2.0-33745816404 10.1016/j.cytogfr.2006.04.003 (Pubitemid 44038615)
48. Gill M., Dias S., Hattori K., Rivera M. L., Hicklin D., Witte L., Girardi L., Yurt R., Himel H., Rafii S., Vascular trauma induces rapid but transient mobilization of VEGFR2+ AC133+ endothelial precursor cells. Circulation Research 2001 88 2 167 174 2-s2.0-0035793330 (Pubitemid 32147304)
49. Zernecke A., Weber C., Inflammatory mediators in atherosclerotic vascular disease. Basic Research in Cardiology 2005 100 2 93 101 2-s2.0-14944378649 10.1007/s00395-005-0511-6 (Pubitemid 40361602)
50. Zhang H., Park Y., Wu J., Role of TNF-alpha in vascular dysfunction. Clinical Science 2009 116 3 219 230 10.1042/CS20080196
51. Rosell A., Arai K., Lok J., He T., Guo S., Navarro M., Montaner J., Katusic Z. S., Lo E. H., Interleukin-1 β augments angiogenic responses of murine endothelial progenitor cells in vitro. Journal of Cerebral Blood Flow and Metabolism 2009 29 5 933 943 2-s2.0-65549097702 10.1038/jcbfm.2009.17
52. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J. M., Asahara T., Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine 1999 5 4 434 438 2-s2.0-0032945433 10.1038/7434 (Pubitemid 29180584)
53. Amano K., Okigaki M., Adachi Y., Fujiyama S., Mori Y., Kosaki A., Iwasaka T., Matsubara H., Mechanism for IL-1 β -mediated neovascularization unmasked by IL-1 β knock-out mice. Journal of Molecular and Cellular Cardiology 2004 36 4 469 480 2-s2.0-1842765614 10.1016/j.yjmcc.2004.01.006 (Pubitemid 38469938)
54. Chen T. G., Zhong Z. Y., Sun G. F., Zhou Y. X., Zhao Y., Effects of tumour necrosis factor-alpha on activity and nitric oxide synthase of endothelial progenitor cells from peripheral blood. Cell Proliferation 2011 44 4 352 359 2-s2.0-79959751427 10.1111/j.1365-2184.2011.00764.x
55. George J., Goldstein E., Abashidze S., Deutsch V., Shmilovich H., Finkelstein A., Herz I., Miller H., Keren G., Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. European Heart Journal 2004 25 12 1003 1008 2-s2.0-3042752502 10.1016/j.ehj.2004.03.026 (Pubitemid 38869417)
56. Sugawara J., Mitsui-Saito M., Hayashi C., Hoshiai T., Senoo M., Chisaka H., Yaegashi N., Okamura K., Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. Journal of Clinical Endocrinology and Metabolism 2005 90 9 5329 5332 2-s2.0-24344433191 10.1210/jc.2005-0532 (Pubitemid 41262296)
57. Verma S., Kuliszewski M. A., Li S. H., Szmitko P. E., Zucco L., Wang C. H., Badiwala M. V., Mickle D. A. G., Weisel R. D., Fedak P. W. M., Stewart D. J., Kutryk M. J. B., C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004 109 17 2058 2067 2-s2.0-2442422177 10.1161/01.CIR.0000127577.63323.24 (Pubitemid 38620212)
58. Suh W., Kim K. L., Choi J. H., Lee Y. S., Lee J. Y., Kim J. M., Jang H. S., Shin I. S., Lee J. S., Byun J., Jeon E. S., Kim D. K., C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells. Biochemical and Biophysical Research Communications 2004 321 1 65 71 2-s2.0-7444247808 10.1016/j.bbrc.2004.06.107
59. Seeger F. H., Haendeler J., Walter D. H., Rochwalsky U., Reinhold J., Urbich C., Rössig L., Corbaz A., Chvatchko Y., Zeiher A. M., Dimmeler S., p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 2005 111 9 1184 1191 2-s2.0-20144371342 10.1161/01.CIR.0000157156. 85397.A1 (Pubitemid 40365481)
60. Chen Y. H., Lin S. J., Lin F. Y., Wu T. C., Tsao C. R., Huang P. H., Liu P. L., Chen Y. L., Chen J. W., High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007 56 6 1559 1568 2-s2.0-34249696575 10.2337/db06-1103 (Pubitemid 46842612)
61. Werner N., Nickenig G., Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 2 257 266 2-s2.0-33644871364 10.1161/01.ATV.0000198239.41189.5d (Pubitemid 43732183)
62. Heeschen C., Lehmann R., Honold J., Assmus B., Aicher A., Walter D. H., Martin H., Zeiher A. M., Dimmeler S., Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004 109 13 1615 1622 2-s2.0-1842507654 10.1161/01.CIR.0000124476.32871.E3 (Pubitemid 38451717)
63. Torsney E., Hu Y., Xu Q., Adventitial progenitor cells contribute to arteriosclerosis. Trends in Cardiovascular Medicine 2005 15 2 64 68 2-s2.0-18844397767 10.1016/j.tcm.2005.02.003 (Pubitemid 40693389)
64. Yao E. H., Yu Y., Fukuda N., Oxidative stress on progenitor and stem cells in cardiovascular diseases. Current Pharmaceutical Biotechnology 2006 7 2 101 108 2-s2.0-33746333507 10.2174/138920106776597685 (Pubitemid 44110357)
65. Griendling K. K., FitzGerald G. A., Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 2003 108 17 2034 2040 2-s2.0-0242349764 10.1161/01.CIR.0000093661.90582.c4 (Pubitemid 37337574)
66. Thum T., Fraccarollo D., Schultheiss M., Froese S., Galuppo P., Widder J. D., Tsikas D., Ertl G., Bauersachs J., Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 2007 56 3 666 674 2-s2.0-33847346061 10.2337/db06-0699 (Pubitemid 46348461)
67. Kao S. T., Yeh C. C., Hsieh C. C., Yang M. D., Lee M. R., Liu H. S., Lin J. G., The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest. Life Sciences 2001 69 13 1485 1496 2-s2.0-0035902794 10.1016/S0024-3205(01)01226-7 (Pubitemid 32786722)
68. Hung Y. C., Sava V. M., Blagodarsky V. A., Hong M. Y., Huang G. S., Protection of tea melanin on hydrazine-induced liver injury. Life Sciences 2003 72 9 1061 1071 2-s2.0-0037449364 10.1016/S0024-3205(02)02348-2 (Pubitemid 35454130)
69. Urbich C., Knau A., Fichtischerer S., Walter D. H., Brühl T., Potente M., Hofmann W. K., De Vos S., Zeiher A. M., Dimmeler S., FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB Journal 2005 19 8 974 976 2-s2.0-20444497875 10.1096/fj.04-2727fje (Pubitemid 40827722)
70. Thum T., Fraccarollo D., Galuppo P., Tsikas D., Frantz S., Ertl G., Bauersachs J., Bone marrow molecular alterations after myocardial infarction: impact on endothelial progenitor cells. Cardiovascular Research 2006 70 1 50 60 2-s2.0-33645067898 10.1016/j.cardiores.2006.01.002
71. Schatteman G. C., Hanlon H. D., Jiao C., Dodds S. G., Christy B. A., Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. Journal of Clinical Investigation 2000 106 4 571 578 2-s2.0-0033857389 (Pubitemid 30666390)
72. Tepper O. M., Galiano R. D., Capla J. M., Kalka C., Gagne P. J., Jacobowitz G. R., Levine J. P., Gurtner G. C., Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002 106 22 2781 2786 2-s2.0-0037180517 10.1161/01.CIR.0000039526.42991.93 (Pubitemid 35396976)
73. Tao J., Yang Z., Wang J. M., Wang L. C., Luo C. F., Tang A. L., Dong Y. G., Ma H., Shear stress increases Cu/Zn SOD activity and mRNA expression in human endothelial progenitor cells. Journal of Human Hypertension 2007 21 5 353 358 2-s2.0-34247341247 10.1038/sj.jhh.1002147 (Pubitemid 46637941)
74. Zhu J. H., Chen J. Z., Wang X. X., Xie X. D., Sun J., Zhang F. R., Homocysteine accelerates senescence andreduces proliferation ofendothelial progenitor cells. Journal of Molecular and Cellular Cardiology 2006 40 5 648 652 2-s2.0-33646101264 10.1016/j.yjmcc.2006.01.011
75. Chen J. W., Chen Y. H., Lin S. J., Long-term exposure to oxidized low-density lipoprotein enhances tumor necrosis factor- α -stimulated endothelial adhesiveness of monocytes by activating superoxide generation and redox-sensitive pathways. Free Radical Biology and Medicine 2006 40 5 817 826 2-s2.0-33644641292 10.1016/j.freeradbiomed.2005.10.037
76. Carracedo J., Merino A., Briceño C., Soriano S., Buendía P., Calleros L., Rodriguez M., Martín-Malo A., Aljama P., Ramírez R., Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. FASEB Journal 2011 25 4 1314 1322 2-s2.0-79954577313 10.1096/fj.10-173377
77. Tso C., Martinic G., Fan W. H., Rogers C., Rye K. A., Barter P. J., High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 5 1144 1149 2-s2.0-33646444759 10.1161/01.ATV.0000216600.37436.cf (Pubitemid 43732125)
78. Zhang Q., Yin H., Liu P., Zhang H., She M., Essential role of HDL on endothelial progenitor cell proliferation with PI3K/Akt/cyclin D1 as the signal pathway. Experimental Biology and Medicine 2010 235 9 1082 1092 2-s2.0-77957164540 10.1258/ebm.2010.010060
79. He T., Peterson T. E., Holmuhamedov E. L., Terzic A., Caplice N. M., Oberley L. W., Katusic Z. S., Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 11 2021 2027 2-s2.0-8344256425 10.1161/01.ATV.0000142810.27849.8f (Pubitemid 39482424)
80. Dernbach E., Urbich C., Brandes R. P., Hofmann W. K., Zeiher A. M., Dimmeler S., Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 2004 104 12 3591 3597 2-s2.0-5344229985 10.1182/blood-2003-12-4103 (Pubitemid 39564432)
81. Shantsila E., Watson T., Lip G. Y. H., Antioxidant protection: yet another function of endothelial progenitor cells? Journal of Human Hypertension 2007 21 5 343 346 2-s2.0-34247505994 10.1038/sj.jhh.1002166 (Pubitemid 46646172)
82. Bjelakovic G., Nikolova D., Gluud L. L., Simonetti R. G., Gluud C., Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. Journal of the American Medical Association 2007 297 8 842 857 2-s2.0-33847378451 10.1001/jama.297.8.842 (Pubitemid 46333949)
83. Redberg R. F., Vitamin supplements: more cost than value. Archives of Internal Medicine 2011 171 18 1634 1635 10.1001/archinternmed.2011.422
84. Bjelakovic G., Gluud C., Vitamin and mineral supplement use in relation to all-cause mortality in the Iowa Women's Health Study. Archives of Internal Medicine 2011 171 18 1633 1634 10.1001/archinternmed.2011.459
85. Mursu J., Robien K., Harnack L. J., Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Archives of Internal Medicine 2011 171 18 1625 1633 10.1001/archinternmed.2011.445
86. Drachman D. E., Simon D. I., Inflammation as a mechanism and therapeutic target for in-stent restenosis. Current Atherosclerosis Reports 2005 7 1 44 49 2-s2.0-15444371185 (Pubitemid 40394229)
87. Di Napoli M., Papa F., Inflammation, blood pressure, and stroke: an opportunity to target primary prevention? Current Hypertension Reports 2005 7 1 44 51 2-s2.0-14044252168 (Pubitemid 40277789)
88. Szmitko P. E., Fedak P. W. M., Weisel R. D., Stewart D. J., Kutryk M. J. B., Verma S., Endothelial progenitor cells: new hope for a broken heart. Circulation 2003 107 24 3093 3100 2-s2.0-0037805771 10.1161/01.CIR.0000074242. 66719.4A (Pubitemid 36758985)
89. Laufs U., Custodis F., Böhm M., HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk. Drugs 2006 66 2 145 154 2-s2.0-32244446516 10.2165/00003495-200666020-00002 (Pubitemid 43213900)
90. Endres M., Statins: potential new indications in inflammatory conditions. Atherosclerosis Supplements 2006 7 1 31 35 2-s2.0-33645094374 10.1016/j.atherosclerosissup.2006.01.005
91. Llevadot J., Murasawa S., Kureishi Y., Uchida S., Masuda H., Kawamoto A., Walsh K., Isner J. M., Asahara T., HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. Journal of Clinical Investigation 2001 108 3 399 405 2-s2.0-0034898468 10.1172/JCI200113131 (Pubitemid 32730786)
92. Walter D. H., Rittig K., Bahlmann F. H., Kirchmair R., Silver M., Murayama T., Nishimura H., Losordo D. W., Asahara T., Isner J. M., Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002 105 25 3017 3024 2-s2.0-0037173080 10.1161/01.CIR.0000018166. 84319.55 (Pubitemid 34693836)
93. Fleissner F., Thum T., Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction. Antioxidants and Redox Signaling 2011 15 4 933 948 2-s2.0-79960392882 10.1089/ars.2010.3502
94. Werner N., Nickenig G., Laufs U., Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Research in Cardiology 2002 97 2 105 116 2-s2.0-0036118915 10.1007/s003950200000 (Pubitemid 34223500)
95. Matsuura K., Hagiwara N., The pleiotropic effects of ARB in vascular endothelial progenitor cells. Current Vascular Pharmacology 2011 9 2 153 157 2-s2.0-79951711994 10.2174/157016111794519345
96. Wang C. H., Verma S., Hsieh I. C., Chen Y. J., Kuo L. T., Yang N. I., Wang S. Y., Wu M. Y., Hsu C. M., Cheng C. W., Cherng W. J., Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. Journal of Molecular and Cellular Cardiology 2006 41 1 34 43 2-s2.0-33745424146 10.1016/j.yjmcc.2006.03.006 (Pubitemid 43946959)
97. Min T. Q., Zhu C. J., Xiang W. X., Hui Z. J., Peng S. Y., Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovascular Drugs and Therapy 2004 18 3 203 209 2-s2.0-3142750485 10.1023/B:CARD.0000033641.33503.bd (Pubitemid 38918955)
98. Bahlmann F. H., De Groot K., Mueller O., Hertel B., Haller H., Fliser D., Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005 45 4 526 529 2-s2.0-15744392514 10.1161/01.HYP.0000159191.98140.89 (Pubitemid 40411254)
99. Skultetyova D., Filipova S., Riecansky I., Skultety J., The role of angiotensin type 1 receptor in inflammation and endothelial dysfunction. Recent Patents on Cardiovascular Drug Discovery 2007 2 1 23 27 2-s2.0-34249285936 10.2174/157489007779606130 (Pubitemid 46813412)
100. Michalik L., Wahli W., Involvement of PPAR nuclear receptors in tissue injury and wound repair. Journal of Clinical Investigation 2006 116 3 598 606 2-s2.0-33644652740 10.1172/JCI27958 (Pubitemid 43326864)
101. Wang C. H., Ciliberti N., Li S. H., Szmitko P. E., Weisel R. D., Fedak P. W. M., Al-Omran M., Cherng W. J., Li R. K., Stanford W. L., Verma S., Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 2004 109 11 1392 1400 2-s2.0-12144289791 10.1161/01.CIR.0000123231.49594.21 (Pubitemid 38387826)
102. Gensch C., Clever Y. P., Werner C., Hanhoun M., Böhm M., Laufs U., The PPAR- γ agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells. Atherosclerosis 2007 192 1 67 74 2-s2.0-34247368097 10.1016/j.atherosclerosis.2006.06.026 (Pubitemid 46628806)
103. Benameur T., Tual-Chalot S., Andriantsitohaina R., Martínez M. C., PPAR α is essential for microparticle-induced differentiation of mouse bone marrow-derived endothelial progenitor cells and angiogenesis. PLoS ONE 2010 5 8 2-s2.0-77957859675 10.1371/journal.pone.0012392 e12392
104. Zhu J. H., Wang X. X., Chen J. Z., Shang Y. P., Zhu J. H., Guo X. G., Sun J., Effects of puerarin on number and activity of endothelial progenitor cells from peripheral blood. Acta Pharmacologica Sinica 2004 25 8 1045 1051 2-s2.0-4043064956 (Pubitemid 39071112)
105. Zhu J., Wang X., Shang Y., Xie X., Zhang F., Chen J., Fu G., Puerarin reduces endothelial progenitor cells senescence through augmentation of telomerase activity. Vascular Pharmacology 2008 49 2-3 106 110 2-s2.0-50849101649 10.1016/j.vph.2008.07.002
106. Gu J., Wang C. Q., Fan H. H., Ding H. Y., Xie X. L., Xu Y. M., Wang B. Y., Huang D. J., Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intima-injured rats. Journal of Cardiovascular Pharmacology 2006 47 5 711 721 2-s2.0-33748132486 10.1097/01.fjc.0000211764.52012.e3 (Pubitemid 44309666)
107. Lefèvre J., Michaud S. É., Haddad P., Dussault S., Ménard C., Groleau J., Turgeon J., Rivard A., Moderate consumption of red wine (cabernet sauvignon) improves ischemia-induced neovascularization in ApoE-deficient mice: effect on endothelial progenitor cells and nitric oxide. FASEB Journal 2007 21 14 3845 3852 2-s2.0-36849031681 10.1096/fj.06-7491com (Pubitemid 350232342)
108. Wang X. B., Huang J., Zou J. G., Su E. B., Shan Q. J., Yang Z. J., Cao K. J., Effects of resveratrol on number and activity of endothelial progenitor cells from human peripheral blood. Clinical and Experimental Pharmacology and Physiology 2007 34 11 1109 1115 2-s2.0-34548696625 10.1111/j.1440-1681.2007. 04667.x (Pubitemid 47416343)
109. Balestrieri M. L., Schiano C., Felice F., Casamassimi A., Balestrieri A., Milone L., Servillo L., Napoli C., Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells. Journal of Biochemistry 2008 143 2 179 186 2-s2.0-39149085689 10.1093/jb/mvm209 (Pubitemid 351249832)
110. Xia L., Wang X. X., Hu X. S., Guo X. G., Shang Y. P., Chen H. J., Zeng C. L., Zhang F. R., Chen J. Z., Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. British Journal of Pharmacology 2008 155 3 387 394 2-s2.0-52949093112 10.1038/bjp.2008.272
111. Huang P. H., Chen Y. H., Tsai H. Y., Chen J. S., Wu T. C., Lin F. Y., Sata M., Chen J. W., Lin S. J., Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 4 869 877 2-s2.0-77950893854 10.1161/ATVBAHA.109.200618
112. Huang P. H., Tsai H. Y., Wang C. H., Chen Y. H., Chen J. S., Lin F. Y., Lin C. P., Wu T. C., Sata M., Chen J. W., Lin S. J., Moderate intake of red wine improves ischemia-induced neovascularization in diabetic mice-Roles of endothelial progenitor cells and nitric oxide. Atherosclerosis 2010 212 2 426 435 2-s2.0-77957701546 10.1016/j.atherosclerosis.2010.06.034
113. Hamed S., Alshiek J., Aharon A., Brenner B., Roguin A., Red wine consumption improves in vitro migration of endothelial progenitor cells in young, healthy individuals. American Journal of Clinical Nutrition 2010 92 1 161 169 2-s2.0-77954586492 10.3945/ajcn.2009.28408
114. Dong X. X., Hui Z. J., Xiang W. X., Rong Z. F., Jian S., Zhu C. J., Ginkgo biloba extract reduces endothelial progenitor-cell senescence through augmentation of telomerase activity. Journal of Cardiovascular Pharmacology 2007 49 2 111 115 2-s2.0-33847218666 10.1097/FJC.0b013e31802ef519
115. Xu M. G., Wang J. M., Chen L., Wang Y., Yang Z., Tao J., Berberine-induced upregulation of circulating endothelial progenitor cells is related to nitric oxide production in healthy subjects. Cardiology 2009 112 4 279 286 2-s2.0-52249113546 10.1159/000157336
116. Li Y. J., Duan C. L., Liu J. X., Xu Y. G., Pro-angiogenic actions of Salvianolic acids on in vitro cultured endothelial progenitor cells and chick embryo chorioallantoic membrane model. Journal of Ethnopharmacology 2010 131 3 562 566 2-s2.0-77956649690 10.1016/j.jep.2010.07.040
117. He W., Wu W. K., Wu Y. L., Yang X. H., Lin Q. X., Yu W. H., Ginsenoside-Rg1 mediates microenvironment-dependent endothelial differentiation of human mesenchymal stem cells in vitro. Journal of Asian Natural Products Research 2011 13 1 1 11 2-s2.0-79251531137 10.1080/10286020.2010.535519
118. Wiernsperger N. F., Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes and Metabolism 2003 29 6 579 585 2-s2.0-0347753692 (Pubitemid 38082159)
119. Williams K. J., Fisher E. A., Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory? Current Opinion in Clinical Nutrition and Metabolic Care 2005 8 2 139 146 2-s2.0-14244251463